Curio Digital Therapeutics Inc. Announces the U.S. Food and Drug Administration (FDA) Clearance of MamaLift Plus™, the First Prescription Digital Therapeutic Authorized for the Treatment of Postpartum Depression (PPD)

NJ-based digital health company Curio Digital Therapeutics Inc. announces 510(k) clearance for MamaLift PlusTM, an eight-week prescription digital therapeutic (PDT) for symptomatic treatment for postpartum depression (PPD). Use of MamaLift Plus should...

Epitel Receives FDA 510(k) Clearance for Two New Technologies: REMI Remote EEG Monitoring System for Ambulatory Use and REMI Vigilenz AI For Event Detection

Advancements help neurologists detect and analyze suspected seizure events from patients in home healthcare settings for extended periods of timeSALT LAKE CITY--(BUSINESS WIRE)--Epitel, a leader in AI technologies for patient-focused brain health solu...

New Study Reveals 65 and Older Population Lowered Blood Pressure, Cholesterol, and Weight Using Mobile Technology

Cardiovascular disease (CVD) affects more than 75 percent of Americans aged 60-79 and more than 90 percent of those aged 80 and over New study shows an overwhelming majority of people aged 65 and over reduced their blood pressure, cholesterol, and...

#RHFH24 unveils the presence of European Health Ministers

The health innovation community is buzzing with anticipation as the Radical Health Festival Helsinki 2024 is about to open its doors. This year’s even…

CharmHealth Unveils 2024 Innovation Challenge to Bring Creative Solutions to the Fingertips of Healthcare Providers

Call for Proposals Now Open to Digital Health Startups to Compete on the CharmHealth EcosystemPLEASANTON, Calif.--(BUSINESS WIRE)--#AI--CharmHealth, a leader in healthcare technology solutions for providers, today announced the kickoff of its 2024 Inn...

SpringTide Ventures Announces the Close of $65 Million Fund II

The new capital will accelerate investments in startups with a clear path to elevating health outcomes on a global scaleBOSTON--(BUSINESS WIRE)--SpringTide Ventures, a leader in early-stage HealthTech venture capital, today announced the successful cl...

Tris Pharma Launches Digital Health Business to Develop and Commercialize Digital Products for ADHD

– Tris Digital Health enters into licensing agreement with Braingaze to develop and commercialize first-in-class, AI-enhanced technology that offers healthcare professionals an objective tool to improve accuracy of ADHD diagnosis – – Tris will conduct...

BEN Partners with OSF HealthCare to Develop AI Solution for Primary Care Training & Patient Evaluation

AI assistants will train healthcare providers on patient assessments and support information collection for diagnosesJACKSON, Wyo.--(BUSINESS WIRE)--Brand Engagement Network (BEN), an emerging provider of personalized customer engagement AI, and OSF H...

Medable Achieves 75% eConsent Adoption Across Elderly Patients in Pivotal U.S. Renal Care Clinical Trial

Patients age 65+ cite efficiency and preference over traditional paper-based consentingPALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc., the leading technology provider for modern clinical trials, achieved an impressive 75% adoption of its Total Conse...

EVERSANA Completes Integration of Healthware Group and Strengthens Its Global Agency Network EVERSANA INTOUCH With Addition of New Full-Service Affiliate

Healthware will operate as the agency network's sixth full-service affiliate, EVERSANA INTOUCH Healthware, serving clients from offices worldwideFulvi…